Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2015 1
2018 2
2019 10
2020 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
[Hange-Shashin-to for preventing diarrhea during afatinib therapy].
Yamaguchi O, Kawashima A, Shiono A, Maeno Y, Ishikawa R, Masumoto A, Utsugi H, Daito H, Okano T, Murayama Y, Kobayashi K. Yamaguchi O, et al. Among authors: murayama y. Gan To Kagaku Ryoho. 2015 May;42(5):581-3. Gan To Kagaku Ryoho. 2015. PMID: 25981651 Japanese.
CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy.
Kagamu H, Kitano S, Yamaguchi O, Yoshimura K, Horimoto K, Kitazawa M, Fukui K, Shiono A, Mouri A, Nishihara F, Miura Y, Hashimoto K, Murayama Y, Kaira K, Kobayashi K. Kagamu H, et al. Among authors: murayama y. Cancer Immunol Res. 2020 Mar;8(3):334-344. doi: 10.1158/2326-6066.CIR-19-0574. Epub 2019 Dec 23. Cancer Immunol Res. 2020. PMID: 31871122
Spontaneous aspiration of a long tree twig as foreign body.
Hashimoto K, Kaira K, Kobayashi K, Murayama Y, Kagamu H. Hashimoto K, et al. Among authors: murayama y. Respirol Case Rep. 2019 Feb 1;7(3):e00401. doi: 10.1002/rcr2.401. eCollection 2019 Apr. Respirol Case Rep. 2019. PMID: 30766681 Free PMC article.
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.
Miura Y, Mouri A, Kaira K, Yamaguchi O, Shiono A, Hashimoto K, Nishihara F, Shinomiya S, Akagami T, Murayama Y, Abe T, Noda SE, Kato S, Kobayashi K, Kagamu H. Miura Y, et al. Among authors: murayama y. Thorac Cancer. 2020 May;11(5):1280-1287. doi: 10.1111/1759-7714.13394. Epub 2020 Mar 11. Thorac Cancer. 2020. PMID: 32160383 Free PMC article.
Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer.
Uchida T, Kaira K, Yamaguchi O, Mouri A, Shiono A, Miura Y, Hashimoto K, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Uchida T, et al. Among authors: murayama y. Thorac Cancer. 2019 Apr;10(4):975-979. doi: 10.1111/1759-7714.13039. Epub 2019 Mar 12. Thorac Cancer. 2019. PMID: 30864291 Free PMC article.
19 results